DW-1350 is an antagonist of LTB4 receptor.

DW-1350 displays inhibitory effects against osteoclast in terms of differentiation, fusion, formation, and bone absorption.

491577-61-8

C25H31N3O3S

453.6

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years